NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-AG-21-055 from the NIH Guide for Grants and Contracts
Notice NOT-AT-21-015 from the NIH Guide for Grants and Contracts
Notice NOT-AT-21-016 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-180 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-179 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-22-009 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites submission of Program Project (P01) applications to support integrated, multi-project research programs examining the pathways by which technology and digital media (TDM) exposure and usage impact developmental trajectories and health outcomes in early childhood (ages birth-8) and adolescence (ages 9-17).
Funding Opportunity RFA-HD-22-005 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites exploratory grant applications, hereafter referred to as the Learning Disabilities Innovation Hubs or LD Hubs, addressing the etiology, manifestation, prevention and remediation of reading, writing and/or mathematics specific learning disorders (SLDs). An LD Hub includes a single research project and a Leadership Core that support the goals and aims of the LD Hub. This FOA seeks to serve as a catalyst to understand and address 1) the needs of diverse, under-represented populations in SLD research, 2) the role technology plays in improving or limiting the learning experiences of children with SLD, including the impact of remote learning on service delivery, family stress, and peer socialization, 3) investigate more complex behavioral phenotypes of learners in SLD research, 4) speed the maturation of nascent/novel, high-impact, high-risk SLD studies that advances research on SLDs and demonstrate potential to directly benefit the SLD community, policy or practice, and 5) provide project embedded, career enhancing research and professional development opportunities to support the next generation of SLD scientists. This initiative provides opportunities to support planning and building of a body of research and corresponding intellectual infrastructure to enable P20 grantees to compete for large research and program project opportunities in the future. This FOA aims to integrate research topics that are of relevance to various research programs at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and align with the NICHD Strategic Plan. The FOA intends to build cross-programmatic, trans-disciplinary and crosscutting scientific research and critically nurture the development of early career researchers capable of conducting this research.
Notice NOT-NS-21-068 from the NIH Guide for Grants and Contracts
Notice NOT-RM-21-032 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-RM-21-014 from the NIH Guide for Grants and Contracts. This limited competition Funding Opportunity Announcement (FOA) solicits applications for the continued development of the Gabriella Miller Kids First Pediatric Data Resource Center (DRC), which consists of the following components: a Data Resource Core, a Data Coordination Core, and an Administrative and Outreach Core. The goal of the cloud-based Data Resource is to accelerate discovery of genetic etiology and shared biologic pathways within and across childhood cancers and structural birth defects by facilitating access to and querying of annotated genomic sequence and phenotypic data from cohorts of patients with these conditions. The Data Resource Core will continue to develop the Data Resource, which serves as an indispensable research resource where genomic and phenotypic data can be aggregated, accessed, analyzed, and shared within and across the childhood cancer and structural birth defects research communities as well as the broader scientific community. The Data Coordination Core will work with Kids First investigators and sequencing centers to facilitate data collection, harmonization, and sharing. The Administrative and Outreach Core will oversee administrative activities, work closely with the NIH Kids First Working Group, and provide outreach and education to the research community on using the Data Resource.
Notice NOT-OD-21-175 from the NIH Guide for Grants and Contracts
Notice NOT-AG-21-020 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-174 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-22-007 from the NIH Guide for Grants and Contracts. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and partnering Institutes invite applications for the Autism Centers of Excellence: Networks Program, hereafter termed ACE Networks. Each ACE Network will consist of a multi-site project focusing on a specific topic of research for R01 support through this FOA. Each ACE Network will submit one R01 application that includes sub-awards to the collaborating sites. A companion FOA (RFA-HD-22-008) invites applications for ACE Centers supported by the P50 mechanism.
Funding Opportunity RFA-HD-22-008 from the NIH Guide for Grants and Contracts. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and partnering Institutes invite applications for the Autism Centers of Excellence: Centers Program, hereafter termed ACE Centers. The P50 mechanism allows for integrative, multi-disciplinary, coordinated programs of research that demonstrate cohesion and synergy across research projects and cores. A companion FOA (RFA-HD-22-007) invites applications for ACE Networks supported by the R01 mechanism.
Notice NOT-MH-21-330 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-282 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and limited-size clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and effectivenesting, design verification and validation activities leading to submission of an Investigational Device Exemption (IDE) to the FDA or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress. Participants in Blueprint MedTech receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants to receive assistance with specialty areas including regulatory, reimbursement, intellectual property, commercialization, and strategic partnerships. Participants can also augment their project with NIH contract research organizations that specialize in large animal testing, sterilization testing, biocompatibility assessment, manufacturing, and medical monitoring. SBCs developing their own devices or that already have established collaborations with device manufacturers are welcome to apply directly to this FOA or any of the companion opportunities. For more information see: https://neuroscienceblueprint.nih.gov/neurotherapeutics/blueprint-medtech
Funding Opportunity RFA-AA-21-016 from the NIH Guide for Grants and Contracts. The FOA seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions with an understanding of the overarching framework for reducing the incidence of new infections by facilitating cross-cutting informative research. This research activity includes the development and testing of new interventions and expansion of existing effective interventions as well as the implementation of these integrative preventive activities in diverse settings and populations. Six areas of research are of primary interest related to alcohol use and related mental health and substance use comorbidities. These include but are not limited to 1) PrEP Utilization, 2) Treatment as Prevention (TasP), 3) Integration of Preventive Intervention Strategies, 4) Prevention-related Cross-cutting Research, 5) Syndemic Approaches and, 6) Implementation and Operations Research.
Funding Opportunity RFA-AA-21-017 from the NIH Guide for Grants and Contracts. The FOA seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions with an understanding of the overarching framework for reducing the incidence of new infections by facilitating cross-cutting informative research. This research activity includes the development and testing of new interventions and expansion of existing effective interventions as well as the implementation of these integrative preventive activities in diverse settings and populations. Six areas of research are of primary interest related to alcohol use and related mental health and substance use comorbidities. These include but are not limited to 1) PrEP Utilization, 2) Treatment as Prevention (TasP), 3) Integration of Preventive Intervention Strategies, 4) Prevention-related Cross-cutting Research, 5) Syndemic Approaches and, 6) Implementation and Operations Research.
Funding Opportunity PAR-21-315 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent clinical feasibility study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress. Participants in Blueprint MedTech receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants to receive assistance with specialty areas including regulatory, reimbursement, intellectual property, commercialization, and strategic partnerships. Participants can also augment their project with NIH contract research organizations that specialize in large animal testing, sterilization testing, biocompatibility assessment, manufacturing, and medical monitoring. Individuals, institutions, or businesses developing their own devices or that already have established collaborations with device manufacturers are welcome to apply directly to this FOA or any of the companion opportunities. For more information see BP MedTech website.